Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Taiwan targets COVID-19 vaccination for 60% of population by Oct

Fri, 28th May 2021 11:26

(Adds comment from Foxconn founder's charity)

By Yimou Lee

TAIPEI, May 28 (Reuters) - Taiwan aims to cover 60% of its
population with at least one dose of coronavirus vaccine by
October, the health minister said on Friday, adding that the
island's infection rate was not good, despite its pandemic
curbs.

Battling a spike in domestic cases, Taiwan announced 555 new
infections on Friday, after months in which the virus was well
under control, and has called its second highest alert to limit
gatherings and shut entertainment venues.

"If we turn on all the firepower for vaccination, the
coverage for the first shot could reach 60%," Health Minister
Chen Shih-chung told a daily news briefing.

Authorities will use a combination of imported and home-made
vaccines to reach that fraction of a population of more than 23
million by the end of October, he said, adding that even
coverage of 40% would be effective to curb the outbreak.

Taiwan has received fewer than one million doses of nearly
30 million on order, as global supply shortages constrict
vaccine deliveries. It has also blamed China for blocking a deal
for vaccines from Germany's BioNTech SE.

With just about 1% of its population vaccinated, Taiwan is
seeking urgent help from allies, such as the United States, to
secure vaccines as domestic criticism mounts over the shortfall.

After pressure from some opposition politicians, Chen said
local governments and companies would be able to import vaccines
directly, but had to follow strict protocols including doing it
through pharmaceutical companies.

The charity of billionaire Terry Gou, founder of Apple Inc
supplier Foxconn, said it was preparing to apply for
permission to be able to import vaccines, but called on the
government to provide clarity on the rules.

Positive cases are currently heavily concentrated in the
capital, Taipei, and its neighbouring city.

Chen said current curbs, such as limits on gatherings, were
effective, but the rise in new infections remained high.

"This is not a very good situation...We are not seeing a
downward trend," Chen said, referring to daily new infections
that have hovered above 400 in the past week.

"There are hidden patients in the community," he added. "We
need to speed up rapid tests in hot spots."

Japan held out the prospect of timely help, saying it would
consider sharing its vaccine doses with other countries after a
ruling party panel urged that a portion of its AstraZeneca Plc
stocks be provided to Taiwan.

The first 150,000 doses of more than 5 million ordered from
Moderna Inc arrived in Taiwan late afternoon on Friday.
(Reporting by Yimou Lee; Editing by Ben Blanchard, Clarence
Fernandez, William Maclean)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.